Potential of Quinine Sulfate for COVID-19 Treatment and Its Safety Profile: Review

References

• Cereda D, Tirani M, Rovida F, et al. The early phase of the COVID-19 outbreak in Lombardy, Italy; 2020. Available from: http://arxiv.org/abs/2003.09320. Accessed November 23, 2021.
   Google Scholar
• Gudbjartsson DF, Helgason A, Jonsson H, et al. Spread of SARS-CoV-2 in the Icelandic population. N Engl J Med. 2020;382(24):2302–2315. doi:10.1056/nejmoa200610032289214
   PubMed Web of Science ®Google Scholar
• Mehra MR, Desai SS, Ruschitzka F, Patel AN. RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet. 2020;6736(20):31180–6. doi:10.1016/S0140-6736(20)31180-6
   Google Scholar
• Gachelin G, Garner P, Ferroni E, Tröhler U, Chalmers I. Evaluating Cinchona bark and quinine for treating and preventing malaria. J R Soc Med. 2017;110(1):31–40. doi:10.1177/014107681668142128106483
   PubMed Web of Science ®Google Scholar
• Lestari K, Sitorus T, Instiaty MS, Levita J. Molecular docking of quinine, chloroquine and hydroxychloroquine to angiotensin converting enzyme 2 (ACE2) receptor for discovering new potential COVID-19 antidote. J Adv Pharm Educ Res. 2020;10(2):1–4.
   Google Scholar
• Große M, Ruetalo N, Businger R, et al. Evidence that quinine exhibits antiviral activity against SARS-CoV-2 infection in vitro. Preprints. 2020;19:2020070102.
   Google Scholar
• Taylor WRJ, White NJ. Antimalarial drug toxicity: a review. Drug Saf. 2004;27(1):25–61. doi:10.2165/00002018-200427010-0000314720085
   PubMed Web of Science ®Google Scholar
• Lim AKH, Ho L, Levidiotis V. Quinine-induced renal failure as a result of rhabdomyolysis, haemolytic uraemic syndrome and disseminated intravascular coagulation. Intern Med J. 2006;36(7):465–467. doi:10.1111/j.1445-5994.2006.01104.x16780456
   PubMed Web of Science ®Google Scholar
• Robinson J. Goodman; 2013. doi:10.4324/9780203813034
   Google Scholar
• Phillipson JD, O’Neill MJ. Novel antimalarial drugs from plants? Parasitol Today. 1986;2(12):355–359. doi:10.1016/0169-4758(86)90058-X15462761
   PubMedGoogle Scholar
• Krafts K, Hempelmann E, Skórska-Stania A. From methylene blue to chloroquine: a brief review of the development of an antimalarial therapy. Parasitol Res. 2012;111(1):1–6. doi:10.1007/s00436-012-2886-x22411634
   PubMed Web of Science ®Google Scholar
• Tzekov R. Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates. Doc Ophthalmol. 2005;110(1):111–120. doi:10.1007/s10633-005-7349-616249962
   PubMed Web of Science ®Google Scholar
• Marella A, Tanwar OP, Saha R, et al. Quinoline: a versatile heterocyclic. Saudi Pharm J. 2013;21(1):1–12. doi:10.1016/j.jsps.2012.03.00223960814
   PubMed Web of Science ®Google Scholar
• Chen YL, Fang KC, Sheu JY, Hsu SL, Tzeng CC. Synthesis and antibacterial evaluation of certain quinolone derivatives. J Med Chem. 2001;44(14):2374–2377. doi:10.1021/jm010033511428933
   PubMed Web of Science ®Google Scholar
• Nqoro X, Tobeka N, Aderibigbe BA. Quinoline-based hybrid compounds with antimalarial activity. Molecules. 2017;22(12):2268. doi:10.3390/molecules22122268
   PubMed Web of Science ®Google Scholar
• Ferlin MG, Chiarelotto G, Gasparotto V, et al. Synthesis and in vitro and in vivo antitumor activity of 2-phenylpyrroloquinolin-4-ones. J Med Chem. 2005;48(9):3417–3427. doi:10.1021/jm049387x15857148
   PubMed Web of Science ®Google Scholar
• Jomsky M. Could low-dose quinine prevent or treat coronavirus infection? Ec Pharmacol Toxicol. 2020:6–9. doi:10.31080/ecpt.2020.08.00455
   Google Scholar
• Quinine _ C20H24N2O2 - PubChem.
   Google Scholar
• Graves PR, Kwiek JJ, Fadden P, et al. Discovery of novel targets of quinoline drugs in the human purine binding proteome. Mol Pharmacol. 2002;62(6):1364–1372. doi:10.1124/mol.62.6.136412435804
   PubMed Web of Science ®Google Scholar
• Kwiek JJ, Haystead TAJ, Rudolph J. Kinetic mechanism of quinone oxidoreductase 2 and its inhibition by the antimalarial quinolines. Biochemistry. 2004;43(15):4538–4547. doi:10.1021/bi035923w15078100
   PubMed Web of Science ®Google Scholar
• Wang M, Cao R, Zhang L, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30(3):269–271. doi:10.1038/s41422-020-0282-032020029
   PubMed Web of Science ®Google Scholar
• Colson P, Rolain JM, Lagier JC, Brouqui P, Raoult D. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents. 2020;55(4):105932. doi:10.1016/j.ijantimicag.2020.10593232145363
   PubMed Web of Science ®Google Scholar
• Gürü M, Gürü S, Yılmaz Aydın D. Effect of alkaloids on SARS-CoV-2. NATURENGS MTU J Eng Nat Sci Mal Turgut Ozal Univ. 2020;10–18. doi:10.46572/nat.2020.7
   Google Scholar
• Bray PG, Mungthin M, Hastings IM, et al. PfCRT and the trans-vacuolar proton electrochemical gradient: regulating the access of chloroquine to ferriprotoporphyrin IX. Mol Microbiol. 2006;62(1):238–251. doi:10.1111/j.1365-2958.2006.05368.x16956382
   PubMed Web of Science ®Google Scholar
• Biot C, Daher W, Chavain N, et al. Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities. J Med Chem. 2006;49(9):2845–2849. doi:10.1021/jm060185616640347
   PubMed Web of Science ®Google Scholar
• Wenhui L, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426(6965):450–454. doi:10.1038/nature0214514647384
   PubMed Web of Science ®Google Scholar
• Kitchen DB, Decornez H, Furr JR, Bajorath J. Docking and scoring in virtual screening for drug discovery: methods and applications. Nat Rev Drug Discov. 2004;3(11):935–949. doi:10.1038/nrd154915520816
   PubMed Web of Science ®Google Scholar
• Benslama O, Mansouri N, Arhab R. Antimalarial phytochemicals as inhibitors against COVID-19 ACE2 receptor: computational screening. Not Sci Biol. 2021;13(2):10835. doi:10.15835/nsb13210835
   Google Scholar
• Sumitha A, Devi PB, Hari S, Dhanasekaran R. COVID-19 - In silico structure prediction and molecular docking studies with doxycycline and quinine. Biomed Pharmacol J. 2020;13(3):1185–1193. doi:10.13005/bpj/1986
   Google Scholar
• Srimathi R, Mohan Maruga Raja MK, Kathiravan MK. In silico screening of traditional herbal medicine derived chemical constituents for possible potential inhibition against sars-cov-2. J Nat Remedies. 2020;20(2):79–88. doi:10.18311/jnr/2020/25278
   Google Scholar
• Roza D, Selly R, Munsirwan R, Fadhilah G. Molecular docking of quinine derivative as inhibitor in Sars-Cov-2. J Phys Conf Ser. 2021;1819(1):012053. doi:10.1088/1742-6596/1819/1/012053
   Google Scholar
• Tallei TE, Tumilaar SG, Niode NJ, et al. Potential of plant bioactive compounds as SARS-CoV-2 main protease (Mpro) and Spike (S) glycoprotein inhibitors: a molecular docking study. Scientifica. 2020;2020. doi:10.1155/2020/6307457
   Web of Science ®Google Scholar
• Xie X, Muruato A, Lokugamage KG, et al. An infectious cDNA clone of SARS-CoV-2. Cell Host Microbe. 2020;27(5):841–848.e3. doi:10.1016/j.chom.2020.04.00432289263
   PubMed Web of Science ®Google Scholar
• Große M, Ruetalo N, Layer M, et al. Quinine inhibits infection of human cell lines with sars-cov-2. Viruses. 2021;13(4):1–17. doi:10.3390/v13040647
   Web of Science ®Google Scholar
• Gendrot M, Andreani J, Boxberger M, et al. Antimalarial drugs inhibit the replication of SARS-CoV-2: an in vitro evaluation. Travel Med Infect Dis. 2020;37:1–6. doi:10.1016/j.tmaid.2020.101873
   Web of Science ®Google Scholar
• Adehin A, Igbinoba SI, Soyinka JO, Onyeji CO, Babalola CP, Bolaji OO. Pharmacokinetic parameters of quinine in healthy subjects and in patients with uncomplicated malaria in Nigeria: analysis of data using a population approach. Curr Ther Res Clin Exp. 2019;91:33–38. doi:10.1016/j.curtheres.2019.10056731871506
   PubMed Web of Science ®Google Scholar
• Minchin RF, Ilett KF. Comparative uptake of quinine and quinidine in rat lung. J Pharm Pharmacol. 1981;33(1):464–466. doi:10.1111/j.2042-7158.1981.tb13835.x6115036
   PubMed Web of Science ®Google Scholar
• Seeler AO, Graessle O, Ott WH. Effect of quinine on influenza virus infections in mice. J Infect Dis. 1946;79(2):156–158. doi:10.1093/infdis/79.2.15620273894
   PubMed Web of Science ®Google Scholar
• Bazotte RB, Hirabara SM, Serdan TAD, et al. 4-aminoquinoline compounds from the Spanish flu to COVID-19. Biomed Pharmacother. 2021;135:111138. doi:10.1016/j.biopha.2020.11113833360781
   PubMed Web of Science ®Google Scholar
• Khan SA, Al-Balushi K. Combating COVID-19: the role of drug repurposing and medicinal plants. J Infect Public Health. 2021;14(4):495–503. doi:10.1016/j.jiph.2020.10.01233743371
   PubMed Web of Science ®Google Scholar
• Kashif M, Aamir M, Minhas S, Tahir R, Jahan S, Afzal N. Myths and facts: chloroquine May be a potential supportive/therapeutic drug in COVID-19 treatment; 2020. doi:10.20944/preprints202004.0341.v1
   Google Scholar
• Baroni A, Paoletti I, Ruocco E, et al. Antiviral effects of quinine sulfate on HSV-1 HaCat cells infected: analysis of the molecular mechanisms involved. J Dermatol Sci. 2007;47(3):253–255. doi:10.1016/j.jdermsci.2007.05.00917600687
   PubMed Web of Science ®Google Scholar
• Al-Bari AA. Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases. J Antimicrob Chemother. 2014;70(6):1608–1621. doi:10.1093/jac/dkv018
   Web of Science ®Google Scholar
• Inklebarger JJIJ, Gyer MG, Galanis N, Michael MJ, Adel DG. Cinchona bark for the treatment of covid-19 pneumonia: a modern review of the potential anti-viral therapeutic applications of an old treatment. Int J Med Sci Clin Invent. 2020;7(5):4795–4801. doi:10.18535/ijmsci/v7i05.02
   Google Scholar
• Jahan I, Onay A. Potentials of plant-based substance to inhabit and probable cure for the covid-19. Turkish J Biol. 2020;44(3):228–241. doi:10.3906/biy-2005-114
   PubMed Web of Science ®Google Scholar
• Shika Tiwari NKD. Traditional medicinal plants as promising source of immunomodulator against Covid-19. J Exp Biol Agric Sci. 2020;8:128–138.
   Google Scholar
• Majnooni MB, Fakhri S, Bahrami G, Naseri M, Farzaei MH, Echeverría J. Alkaloids as potential phytochemicals against SARS-CoV-2: approaches to the associated pivotal mechanisms. Evid Based Complement Altern Med. 2021;2021:1–21. doi:10.1155/2021/6632623
   Web of Science ®Google Scholar
• Malakar S, Sreelatha L, Dechtawewat T, et al. Drug repurposing of quinine as antiviral against dengue virus infection. Virus Res. 2018;255:171–178. doi:10.1016/j.virusres.2018.07.01830055216
   PubMed Web of Science ®Google Scholar
• Noisakran JA, Punt J, Stranford SA. WHF. In: Kuby Immunology. 7th ed; 2009.
   Google Scholar
• Sadler AJ, Williams BRG. Interferon-inducible antiviral effectors. Nat Rev Immunol. 2008;8(7):559–568. doi:10.1038/nri231418575461
   PubMed Web of Science ®Google Scholar
• Nugraha RV, Ridwansyah H, Ghozali M, Khairani AF, Atik N. Traditional herbal medicine candidates as complementary treatments for COVID-19: a review of their mechanisms, pros and cons. Evid Based Complement Altern Med. 2020;2020:1–12. doi:10.1155/2020/2560645
   Web of Science ®Google Scholar
• Maruyama N, Kakuta Y, Yamauchi K, et al. Quinine inhibits production of tumor necrosis factor-alpha from human alveolar macrophages. Am J Respir Cell Mol Biol. 1994;10(5):514–520. doi:10.1165/ajrcmb.10.5.81799138179913
   PubMed Web of Science ®Google Scholar
• Ittarat W, Udomsangpetch R, Chotivanich KT, Looareesuwan S. The effects of quinine and artesunate treatment on plasma tumor necrosis factor levels in malaria-infected patients. Southeast Asian J Trop Med Public Health. 1999;30(1):7–10.10695778
   PubMedGoogle Scholar
• Margolin L, Luchins J, Margolin D, Margolin M, Lefkowitz S. 20-week study of clinical outcomes of over-the-counter COVID-19 prophylaxis and treatment. J Evid Based Integr Med. 2021;26:1–13. doi:10.1177/2515690X211026193
   Web of Science ®Google Scholar
• Liu W, Qi Y, Liu L, Tang Y, Wei J, Zhou L. Suppression of tumor cell proliferation by quinine via the inhibition of the tumor necrosis factor receptor-associated factor 6-AKT interaction. Mol Med Rep. 2016;14(3):2171–2179. doi:10.3892/mmr.2016.549227430155
   PubMed Web of Science ®Google Scholar
• Higgins PDR, Ng S, Danese S, Rao K. The risk of SARS-CoV-2 in immunosuppressed IBD patients. Crohn’s Colitis 360. 2020;2(2):1–4. doi:10.1093/crocol/otaa026
   Google Scholar
• Brent J, Burkhart K, Dargan P, et al. Critical Care Toxicology: Diagnosis and Management of the Critically Poisoned Patient. Springer, Cham. 2017:1–3058. doi:10.1007/978-3-319-17900-1.
   Google Scholar
• Achan J, Talisuna AO, Erhart A, et al. Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria. Malar J. 2011;10(1):1–12. doi:10.1186/1475-2875-10-14421214892
   PubMed Web of Science ®Google Scholar
• Bar-Oz B, Levichek Z, Koren G. Medications that can be fatal for a toddler with one tablet or teaspoonful: a 2004 update. Pediatr Drugs. 2004;6(2):123–126. doi:10.2165/00148581-200406020-00005
   PubMedGoogle Scholar
• Jm V. Chemotherapy of malaria. In: The Pharmacological Basis of Therapeutics. 13th ed. Mcgraw-Hill Education; 2017:969–988. Available from: https://accessmedicine.mhmedical.com/content.aspx?bookid=2189&sectionid=172484142.
   Google Scholar
• Adam Bykowski TDL. Chinconism. StatPearls Publishing; 2020. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559319/#_article-19560_s15_.
   Google Scholar
• Manzano-Santana PI, Tivillin JPP, Chóez-Guaranda IA, Lucas ADB, Orellana-Manzano AK, Rastrelli L. Potential bioactive compounds of medicinal plants against new Coronavirus (SARS-CoV-2): a review. Rev Bionatura. 2021;6(1):1653–1658. doi:10.21931/RB/2021.06.01.30
   Google Scholar